{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T22:45:22Z","timestamp":1776206722194,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100011541","name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["R37CA272883"],"award-info":[{"award-number":["R37CA272883"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1038\/s41375-024-02363-y","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T07:01:49Z","timestamp":1728889309000},"page":"42-50","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Functional variant rs9344 at 11q13.3 regulates CCND1 expression in multiple myeloma with t(11;14)"],"prefix":"10.1038","volume":"39","author":[{"given":"Hongwei","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0756-2922","authenticated-orcid":false,"given":"Huihuang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suganti","family":"Shivaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey","family":"Lehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8229-3083","authenticated-orcid":false,"given":"Neeraj","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Smadbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinthya","family":"Zepeda-Mendoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shulan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Asmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1962-9322","authenticated-orcid":false,"given":"Celine","family":"Vachon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8528-5575","authenticated-orcid":false,"given":"Alexandre","family":"Gaspar Maia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4375-7399","authenticated-orcid":false,"given":"Jonathan","family":"Keats","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1523-7388","authenticated-orcid":false,"given":"P. Leif","family":"Bergsagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5938-3769","authenticated-orcid":false,"given":"Rafael","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Keith","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel-Sean","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0894-1222","authenticated-orcid":false,"given":"Richard K.","family":"Kandasamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9943-6127","authenticated-orcid":false,"given":"Akhilesh","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcella A.","family":"Kaddoura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5017-1620","authenticated-orcid":false,"given":"Francesco","family":"Maura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4046-7070","authenticated-orcid":false,"given":"Amit","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5862-1833","authenticated-orcid":false,"given":"S. Vincent","family":"Rajkumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5392-9284","authenticated-orcid":false,"given":"Shaji K.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eran","family":"Elhaik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3860-4830","authenticated-orcid":false,"given":"Esteban","family":"Braggio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5229-4897","authenticated-orcid":false,"given":"Linda B.","family":"Baughn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"key":"2363_CR1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41571-018-0018-y","volume":"15","author":"SK Kumar","year":"2018","unstructured":"Kumar SK, Rajkumar SV. The multiple myelomas - current concepts in cytogenetic classification and therapy. Nat Rev Clin Oncol. 2018;15:409\u201321.","journal-title":"Nat Rev Clin Oncol"},{"key":"2363_CR2","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/ng.2583","volume":"45","author":"N Weinhold","year":"2013","unstructured":"Weinhold N, Johnson DC, Chubb D, Chen B, Forsti A, Hosking FJ, et al. The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma. Nat Genet. 2013;45:522\u20135.","journal-title":"Nat Genet"},{"key":"2363_CR3","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-020-0294-5","volume":"10","author":"LB Baughn","year":"2020","unstructured":"Baughn LB, Li Z, Pearce K, Vachon CM, Polley MY, Keats J, et al. The CCND1 c.870G risk allele is enriched in individuals of African ancestry with plasma cell dyscrasias. Blood Cancer J. 2020;10:39.","journal-title":"Blood Cancer J"},{"key":"2363_CR4","first-page":"1401","volume":"7","author":"M Seto","year":"1992","unstructured":"Seto M, Yamamoto K, Iida S, Akao Y, Utsumi KR, Kubonishi I, et al. Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation. Oncogene 1992;7:1401\u20136.","journal-title":"Oncogene"},{"key":"2363_CR5","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-019-0255-z","volume":"9","author":"J Smadbeck","year":"2019","unstructured":"Smadbeck J, Peterson JF, Pearce KE, Pitel BA, Figueroa AL, Timm M, et al. Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma. Blood Cancer J. 2019;9:103.","journal-title":"Blood Cancer J"},{"key":"2363_CR6","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.1158\/1078-0432.CCR-21-0005","volume":"27","author":"N Sharma","year":"2021","unstructured":"Sharma N, Smadbeck JB, Abdallah N, Zepeda-Mendoza C, Binder M, Pearce KE, et al. The prognostic role of MYC structural variants identified by NGS and FISH in multiple myeloma. Clin Cancer Res. 2021;27:5430\u20139.","journal-title":"Clin Cancer Res"},{"key":"2363_CR7","doi-asserted-by":"crossref","unstructured":"Skerget S, Penaherrera D, Chari A, Jagannath S, Siegel DS, Vij R, et al. Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes. Nat Genet. 2024;56:1878\u201389.","DOI":"10.1038\/s41588-024-01853-0"},{"key":"2363_CR8","doi-asserted-by":"crossref","DOI":"10.1186\/s12864-017-4371-5","volume":"18","author":"J Zhong","year":"2017","unstructured":"Zhong J, Ye Z, Lenz SW, Clark CR, Bharucha A, Farrugia G, et al. Purification of nanogram-range immunoprecipitated DNA in ChIP-seq application. BMC Genom. 2017;18:985.","journal-title":"BMC Genom"},{"key":"2363_CR9","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/nmeth.4396","volume":"14","author":"MR Corces","year":"2017","unstructured":"Corces MR, Trevino AE, Hamilton EG, Greenside PG, Sinnott-Armstrong NA, Vesuna S, et al. An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues. Nat Methods. 2017;14:959\u201362.","journal-title":"Nat Methods"},{"key":"2363_CR10","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013;8:2281\u2013308.","journal-title":"Nat Protoc"},{"key":"2363_CR11","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2005-01-0034","volume":"106","author":"PL Bergsagel","year":"2005","unstructured":"Bergsagel PL, Kuehl WM, Zhan F, Sawyer J, Barlogie B, Shaughnessy J Jr. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. Blood. 2005;106:296\u2013303.","journal-title":"Blood"},{"key":"2363_CR12","doi-asserted-by":"publisher","unstructured":"Herrera-Luis E, Benke K, Volk H, Ladd-Acosta C, Wojcik GL. Gene\u2013environment interactions in human health. Nat Rev Genet. 2024:1\u201317. https:\/\/doi.org\/10.1038\/s41576-024-00731-z.","DOI":"10.1038\/s41576-024-00731-z"},{"key":"2363_CR13","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1093\/bioinformatics\/btv402","volume":"31","author":"MJ Machiela","year":"2015","unstructured":"Machiela MJ, Chanock SJ. LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics. 2015;31:3555\u20137.","journal-title":"Bioinformatics"},{"key":"2363_CR14","volume":"19","author":"Y Wang","year":"2018","unstructured":"Wang Y, Song F, Zhang B, Zhang L, Xu J, Kuang D, et al. The 3D genome browser: a web-based browser for visualizing 3D genome organization and long-range chromatin interactions. Genome Biol. 2018;19:151.","journal-title":"Genome Biol"},{"key":"2363_CR15","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.cell.2014.11.021","volume":"159","author":"SS Rao","year":"2014","unstructured":"Rao SS, Huntley MH, Durand NC, Stamenova EK, Bochkov ID, Robinson JT, et al. A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell. 2014;159:1665\u201380.","journal-title":"Cell"},{"key":"2363_CR16","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-25704-2","volume":"12","author":"J Alvarez-Benayas","year":"2021","unstructured":"Alvarez-Benayas J, Trasanidis N, Katsarou A, Ponnusamy K, Chaidos A, May PC, et al. Chromatin-based, in cis and in trans regulatory rewiring underpins distinct oncogenic transcriptomes in multiple myeloma. Nat Commun. 2021;12:5450.","journal-title":"Nat Commun"},{"key":"2363_CR17","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1016\/j.celrep.2018.12.016","volume":"25","author":"M Fulciniti","year":"2018","unstructured":"Fulciniti M, Lin CY, Samur MK, Lopez MA, Singh I, Lawlor MA, et al. Non-overlapping Control of transcriptome by promoter- and super-enhancer-associated dependencies in multiple myeloma. Cell Rep. 2018;25:3693\u2013705 e3696.","journal-title":"Cell Rep"},{"key":"2363_CR18","volume":"11","author":"Y Jia","year":"2021","unstructured":"Jia Y, Zhou J, Tan TK, Chung TH, Wong RWJ, Chooi JY, et al. Myeloma-specific superenhancers affect genes of biological and clinical relevance in myeloma. Blood Cancer J. 2021;11:32.","journal-title":"Blood Cancer J"},{"key":"2363_CR19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature14248","volume":"518","author":"A Kundaje","year":"2015","unstructured":"Roadmap Epigenomics C, Kundaje A, Meuleman W, Ernst J, Bilenky M, Yen A, et al. Integrative analysis of 111 reference human epigenomes. Nature. 2015;518:317\u201330.","journal-title":"Nature"},{"key":"2363_CR20","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cell.2013.09.053","volume":"155","author":"D Hnisz","year":"2013","unstructured":"Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-Andre V, Sigova AA, et al. Super-enhancers in the control of cell identity and disease. Cell. 2013;155:934\u201347.","journal-title":"Cell"},{"key":"2363_CR21","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.7150\/thno.54453","volume":"12","author":"E Alaterre","year":"2022","unstructured":"Alaterre E, Ovejero S, Herviou L, de Boussac H, Papadopoulos G, Kulis M, et al. Comprehensive characterization of the epigenetic landscape in Multiple Myeloma. Theranostics. 2022;12:1715\u201329.","journal-title":"Theranostics"},{"key":"2363_CR22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13045-020-00933-y","volume":"13","author":"SR Choudhury","year":"2020","unstructured":"Choudhury SR, Ashby C, Tytarenko R, Bauer M, Wang Y, Deshpande S, et al. The functional epigenetic landscape of aberrant gene expression in molecular subgroups of newly diagnosed multiple myeloma. J Hematol Oncol. 2020;13:108.","journal-title":"J Hematol Oncol"},{"key":"2363_CR23","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1101\/gr.276042.121","volume":"32","author":"A Mikulasova","year":"2022","unstructured":"Mikulasova A, Kent D, Trevisan-Herraz M, Karataraki N, Fung KTM, Ashby C, et al. Epigenomic translocation of H3K4me3 broad domains over oncogenes following hijacking of super-enhancers. Genome Res. 2022;32:1343\u201354.","journal-title":"Genome Res"},{"key":"2363_CR24","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1126\/science.1243490","volume":"342","author":"AB Stergachis","year":"2013","unstructured":"Stergachis AB, Haugen E, Shafer A, Fu W, Vernot B, Reynolds A, et al. Exonic transcription factor binding directs codon choice and affects protein evolution. Science. 2013;342:1367\u201372.","journal-title":"Science"},{"key":"2363_CR25","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1101\/gr.133546.111","volume":"22","author":"RY Birnbaum","year":"2012","unstructured":"Birnbaum RY, Clowney EJ, Agamy O, Kim MJ, Zhao J, Yamanaka T, et al. Coding exons function as tissue-specific enhancers of nearby genes. Genome Res. 2012;22:1059\u201368.","journal-title":"Genome Res"},{"key":"2363_CR26","doi-asserted-by":"crossref","first-page":"e1004592","DOI":"10.1371\/journal.pgen.1004592","volume":"10","author":"RY Birnbaum","year":"2014","unstructured":"Birnbaum RY, Patwardhan RP, Kim MJ, Findlay GM, Martin B, Zhao J, et al. Systematic dissection of coding exons at single nucleotide resolution supports an additional role in cell-specific transcriptional regulation. PLoS Genet. 2014;10:e1004592.","journal-title":"PLoS Genet"},{"key":"2363_CR27","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/sj.onc.1209371","volume":"25","author":"KE Knudsen","year":"2006","unstructured":"Knudsen KE, Diehl JA, Haiman CA, Knudsen ES. Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene 2006;25:1620\u20138.","journal-title":"Oncogene"},{"key":"2363_CR28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ajpath.2013.03.001","volume":"183","author":"RG Pestell","year":"2013","unstructured":"Pestell RG. New roles of cyclin D1. Am J Pathol. 2013;183:3\u20139.","journal-title":"Am J Pathol"},{"key":"2363_CR29","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1182\/blood-2006-04-016634","volume":"108","author":"M Marzec","year":"2006","unstructured":"Marzec M, Kasprzycka M, Lai R, Gladden AB, Wlodarski P, Tomczak E, et al. Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity. Blood. 2006;108:1744\u201350.","journal-title":"Blood"},{"key":"2363_CR30","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3324\/haematol.2019.217927","volume":"105","author":"A Mikulasova","year":"2020","unstructured":"Mikulasova A, Ashby C, Tytarenko RG, Qu P, Rosenthal A, Dent JA, et al. Microhomology-mediated end joining drives complex rearrangements and overexpression of MYC and PVT1 in multiple myeloma. Haematologica. 2020;105:1055\u201366.","journal-title":"Haematologica"},{"key":"2363_CR31","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1101\/gr.276028.121","volume":"32","author":"D Rico","year":"2022","unstructured":"Rico D, Kent D, Karataraki N, Mikulasova A, Berlinguer-Palmini R, Walker BA, et al. High-resolution simulations of chromatin folding at genomic rearrangements in malignant B cells provide mechanistic insights into proto-oncogene deregulation. Genome Res. 2022;32:1355\u201366.","journal-title":"Genome Res"},{"key":"2363_CR32","first-page":"275","volume":"18","author":"N Tsuyama","year":"2019","unstructured":"Tsuyama N, Abe Y, Yanagi A, Yanai Y, Sugai M, Katafuchi A, et al. Induction of t(11;14) IgH enhancer\/promoter-cyclin D1 gene translocation using CRISPR\/Cas9. Oncol Lett. 2019;18:275\u201382.","journal-title":"Oncol Lett"},{"key":"2363_CR33","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.4049\/jimmunol.178.5.3031","volume":"178","author":"M Fuxa","year":"2007","unstructured":"Fuxa M, Busslinger M. Reporter gene insertions reveal a strictly B lymphoid-specific expression pattern of Pax5 in support of its B cell identity function. J Immunol. 2007;178:3031\u20137.","journal-title":"J Immunol"},{"key":"2363_CR34","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1182\/blood.V100.13.4629","volume":"100","author":"ND Borson","year":"2002","unstructured":"Borson ND, Lacy MQ, Wettstein PJ. Altered mRNA expression of Pax5 and Blimp-1 in B cells in multiple myeloma. Blood. 2002;100:4629\u201339.","journal-title":"Blood"},{"key":"2363_CR35","first-page":"2950","volume":"12","author":"S Bal","year":"2022","unstructured":"Bal S, Kumar SK, Fonseca R, Gay F, Hungria VT, Dogan A, et al. Multiple myeloma with t(11;14): unique biology and evolving landscape. Am J Cancer Res. 2022;12:2950\u201365.","journal-title":"Am J Cancer Res"},{"key":"2363_CR36","doi-asserted-by":"crossref","unstructured":"Leblay N, Ahn S, Tilmont R, Poorebrahim M, Maity R, Lee H, et al. Integrated epigenetic and transcriptional single-cell analysis of t(11;14) multiple myeloma and Its BCL2 dependency. Blood. 2023;143:42\u201356.","DOI":"10.1182\/blood.2023020276"},{"key":"2363_CR37","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1182\/blood-2002-11-3333","volume":"102","author":"N Robillard","year":"2003","unstructured":"Robillard N, Avet-Loiseau H, Garand R, Moreau P, Pineau D, Rapp MJ, et al. CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma. Blood. 2003;102:1070\u20131.","journal-title":"Blood"},{"key":"2363_CR38","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/modpathol.3800169","volume":"17","author":"P Lin","year":"2004","unstructured":"Lin P, Mahdavy M, Zhan F, Zhang HZ, Katz RL, Shaughnessy JD. Expression of PAX5 in CD20-positive multiple myeloma assessed by immunohistochemistry and oligonucleotide microarray. Mod Pathol. 2004;17:1217\u201322.","journal-title":"Mod Pathol"},{"key":"2363_CR39","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1182\/blood-2005-11-013458","volume":"108","author":"F Zhan","year":"2006","unstructured":"Zhan F, Huang Y, Colla S, Stewart JP, Hanamura I, Gupta S, et al. The molecular classification of multiple myeloma. Blood. 2006;108:2020\u20138.","journal-title":"Blood"},{"key":"2363_CR40","volume":"12","author":"X Lu","year":"2021","unstructured":"Lu X, Chen X, Forney C, Donmez O, Miller D, Parameswaran S, et al. Global discovery of lupus genetic risk variant allelic enhancer activity. Nat Commun. 2021;12:1611.","journal-title":"Nat Commun"},{"key":"2363_CR41","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1126\/science.aac6948","volume":"350","author":"EK Farley","year":"2015","unstructured":"Farley EK, Olson KM, Zhang W, Brandt AJ, Rokhsar DS, Levine MS. Suboptimization of developmental enhancers. Science. 2015;350:325\u20138.","journal-title":"Science"},{"key":"2363_CR42","doi-asserted-by":"crossref","first-page":"e76500","DOI":"10.7554\/eLife.76500","volume":"11","author":"MG Yang","year":"2022","unstructured":"Yang MG, Ling E, Cowley CJ, Greenberg ME, Vierbuchen T. Characterization of sequence determinants of enhancer function using natural genetic variation. Elife. 2022;11:e76500.","journal-title":"Elife"},{"key":"2363_CR43","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1097-2765(02)00459-8","volume":"9","author":"LA Cirillo","year":"2002","unstructured":"Cirillo LA, Lin FR, Cuesta I, Friedman D, Jarnik M, Zaret KS. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol Cell. 2002;9:279\u201389.","journal-title":"Mol Cell"},{"key":"2363_CR44","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/s41588-018-0140-x","volume":"50","author":"J Jacobs","year":"2018","unstructured":"Jacobs J, Atkins M, Davie K, Imrichova H, Romanelli L, Christiaens V, et al. The transcription factor Grainy head primes epithelial enhancers for spatiotemporal activation by displacing nucleosomes. Nat Genet. 2018;50:1011\u201320.","journal-title":"Nat Genet"},{"key":"2363_CR45","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1101\/gr.260851.120","volume":"31","author":"ZK Atak","year":"2021","unstructured":"Atak ZK, Taskiran II, Demeulemeester J, Flerin C, Mauduit D, Minnoye L, et al. Interpretation of allele-specific chromatin accessibility using cell state-aware deep learning. Genome Res. 2021;31:1082\u201396.","journal-title":"Genome Res"},{"key":"2363_CR46","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1038\/emboj.2012.155","volume":"31","author":"IDR Revilla","year":"2012","unstructured":"Revilla IDR, Bilic I, Vilagos B, Tagoh H, Ebert A, Tamir IM, et al. The B-cell identity factor Pax5 regulates distinct transcriptional programmes in early and late B lymphopoiesis. EMBO J. 2012;31:3130\u201346.","journal-title":"EMBO J"},{"key":"2363_CR47","doi-asserted-by":"crossref","first-page":"e20230260","DOI":"10.1084\/jem.20230260","volume":"220","author":"S Gruenbacher","year":"2023","unstructured":"Gruenbacher S, Jaritz M, Hill L, Schafer M, Busslinger M. Essential role of the Pax5 C-terminal domain in controlling B cell commitment and development. J Exp Med. 2023;220:e20230260.","journal-title":"J Exp Med"},{"key":"2363_CR48","doi-asserted-by":"crossref","first-page":"e1007642","DOI":"10.1371\/journal.pgen.1007642","volume":"14","author":"MR Hart","year":"2018","unstructured":"Hart MR, Anderson DJ, Porter CC, Neff T, Levin M, Horwitz MS. Activating PAX gene family paralogs to complement PAX5 leukemia driver mutations. PLoS Genet. 2018;14:e1007642.","journal-title":"PLoS Genet"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-024-02363-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-024-02363-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-024-02363-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T11:03:39Z","timestamp":1736420619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-024-02363-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,14]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["2363"],"URL":"https:\/\/doi.org\/10.1038\/s41375-024-02363-y","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,14]]},"assertion":[{"value":"8 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SKK served as a consultant for Celgene, Takeda, Amgen, Janssen, and Bristol-Myers Squibb, and received research funding from Celgene, Takeda, Novartis, Amgen, AbbVie, Janssen, and Bristol-Myers Squibb. LBB served as a consultant for Genentech. Eran Elhaik is a consultant at the DNA Diagnostics Centre. AKS Amgen, Glaxo Smith Klein, Genentech, Janssen, Ono, Skyline Diagnostics, Tempus Labs Inc. RF Consulting: AbbVie, Adaptive Biotechnologies, AMGEN, AZeneca, Bayer, Binding Site, BMS (Celgene), Millenium Takeda, Jansen, Juno, Kite, Merck, Pfizer, Pharmacyclics, RA Capital, Regeneron, Sanofi. Scientific Advisory Boards: Adaptive Biotechnologies, Caris Life Sciences, Oncotracker. Board of Directors: Antegene (for profit), AZBio (not for Profit), patent for FISH in MM. The remaining authors declare no competing financial interests relevant to the project.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}